3
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found

      Increased Adiposity and Altered Adipocyte Function in Female Survivors of Childhood Acute Lymphoblastic Leukaemia Treated without Cranial Radiation

      research-article

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background: Excess adiposity is a complication of childhood acute lymphoblastic leukaemia (ALL) and is commonly attributed to cranial radiation (CRT) administration. Hyperleptinaemia also occurs during ALL treatment, but there are no data on long-term alterations to adipocytokines following treatment without CRT. Methods: Fifty-four survivors (50% female) and 51 controls (59% female) were recruited. Body composition assessment was by BMI, air displacement plethysmography (BODPOD), bioelectrical impedance analysis (BIA) and skinfold thickness (SFT). Fasting blood samples were analysed for adipocytokines (leptin, adiponectin, resistin, tumour necrosis factor-α, interleukin-6). Results: The BMI standard deviation score (0.71 vs. 0.04, p < 0.05) and fat percentage measured by BIA (29.8% vs. 24.6%, p = 0.01) and SFT (31.7% vs. 28.2%, p = 0.007) were greater in female survivors compared with controls. Adiposity was similar in male survivors and controls. Absolute leptin (17.8 vs. 7.8 ng/ml, p = 0.01) and fat-adjusted leptin concentrations (p < 0.05) were higher in female survivors compared to controls. Female survivors were less insulin sensitive than controls (p = 0.02). These findings were not observed in males. There were no differences in the other adipocytokines between survivors and controls. Conclusions: Long-term unfavourable alterations to body composition and adipocyte function are observed in female, but not male, survivors of ALL treatment without CRT.

          Related collections

          Most cited references30

          • Record: found
          • Abstract: not found
          • Article: not found

          The assessment of the amount of fat in the human body from measurements of skinfold thickness

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Tracking of activity and sedentary behaviors in childhood: the Iowa Bone Development Study.

            Physical activity tracking studies can determine when children settle into activity patterns and their risk for maintaining sedentary behaviors. This study examined the tracking of activity and sedentary behavior in relation to adiposity during middle childhood. Activity intensities and patterns were examined during a 3-year interval in a population-based study of children using accelerometry and survey methods. Data were collected and analyzed from 1998 to 2004. Participants (n = 379) were, on average, 5.6 (standard deviation [SD] +/- 0.5) years at baseline and 8.6 (SD +/- 0.5) years at follow-up. Adiposity was measured with whole-body, dual-energy x-ray absorptiometry. Correlation coefficients and odds ratios were used to assess tracking. The association of activity with adiposity was tested using the Wilcoxon rank-sum test. Over the 3-year interval, Spearman rank-order correlation coefficients between baseline and follow-up activity measures were low to moderate (r = 0.18 to 0.39). Sedentary behavior was more predictable than overall activity, and tended to be more stable (r = 0.37 to 0.52), with the exception of video playing in boys (r = 0.18). Children maintaining a high degree of vigorous activity and low levels of TV viewing were less likely than peers to be in the upper quartile for adiposity at follow-up, and were less likely to gain adiposity during the study period. Sedentary behavior, including TV viewing, is moderately stable during middle childhood. Health promotion programs that specifically target maintaining high levels of vigorous activity and low levels of TV viewing may help reduce the increasing prevalence of childhood obesity.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95.

              The trial ALL-BFM 95 for treatment of childhood acute lymphoblastic leukemia was designed to reduce acute and long-term toxicity in selected patient groups with favorable prognosis and to improve outcome in poor-risk groups by treatment intensification. These aims were pursued through a stratification strategy using white blood cell count, age, immunophenotype, treatment response, and unfavorable genetic aberrations providing an excellent discrimination of risk groups. Estimated 6-year event-free survival (6y-pEFS) for all 2169 patients was 79.6% (+/- 0.9%). The large standard-risk (SR) group (35% of patients) achieved an excellent 6y-EFS of 89.5% (+/- 1.1%) despite significant reduction of anthracyclines. In the medium-risk (MR) group (53% of patients), 6y-pEFS was 79.7% (+/- 1.2%); no improvement was accomplished by the randomized use of additional intermediate-dose cytarabine after consolidation. Omission of preventive cranial irradiation in non-T-ALL MR patients was possible without significant reduction of EFS, although the incidence of central nervous system relapses increased. In the high-risk (HR) group (12% of patients), intensification of consolidation/reinduction treatment led to considerable improvement over the previous ALL-BFM trials yielding a 6y-pEFS of 49.2% (+/- 3.2%). Compared without previous trial ALL-BFM 90, consistently favorable results in non-HR patients were achieved with significant treatment reduction in the majority of these patients.
                Bookmark

                Author and article information

                Journal
                HRP
                Horm Res Paediatr
                10.1159/issn.1663-2818
                Hormone Research in Paediatrics
                S. Karger AG
                1663-2818
                1663-2826
                2011
                June 2011
                05 April 2011
                : 75
                : 6
                : 433-440
                Affiliations
                aPaediatric Oncology and bPaediatric Endocrinology, Southampton University Hospitals NHS Trust, Southampton, UK
                Author notes
                *Dr. Justin H. Davies, MP43, Child Health Directorate, Southampton University Hospital Trust, Tremona Road, Southampton SO16 6YD (UK), Tel. +44 2380 796 985, E-Mail justin.davies@suht.swest.nhs.uk
                Article
                324412 Horm Res Paediatr 2011;75:433–440
                10.1159/000324412
                21464554
                72abb63f-2b3e-4d2e-b389-eb332bb941a7
                © 2011 S. Karger AG, Basel

                Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

                History
                : 16 July 2010
                : 14 January 2011
                Page count
                Tables: 3, Pages: 8
                Categories
                Original Paper

                Endocrinology & Diabetes,Neurology,Nutrition & Dietetics,Sexual medicine,Internal medicine,Pharmacology & Pharmaceutical medicine
                Leukaemia,Adiposity,Glucocorticoids,Adipokines,Leptin

                Comments

                Comment on this article